Qomel Company Limited (TADAWUL:9600)
Saudi Arabia · Delayed Price · Currency is SAR
54.00
+3.00 (5.88%)
May 4, 2026, 2:55 PM AST
Revenue by Segment
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
Sale of Medicines and Medical Products | 132.23M | 124.20M | 105.47M | 77.71M | 61.23M |
Sale of Medicines and Medical Products Growth | 6.46% | 17.76% | 35.72% | 26.93% | - |
| 132.23M | 124.20M | 105.47M | 77.71M | 61.23M |
| 6.46% | 17.76% | 35.72% | 26.93% | - |
Revenue by Geography
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 132.23M | 124.20M | 105.47M | 77.71M | 61.23M |
Kingdom of Saudi Arabia Growth | 6.46% | 17.76% | 35.72% | 26.93% | - |
| 132.23M | 124.20M | 105.47M | 77.71M | 61.23M |
| 6.46% | 17.76% | 35.72% | 26.93% | - |
Source: S&P Global Market Intelligence.
